RDY Revenue Per Share vs Ebit Per Revenue Analysis

RDY Stock

USD 13.79 0.15 1.08%

Dr Reddys financial indicator trend analysis is much more than just examining Dr Reddys Laboratories latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dr Reddys Laboratories is a good investment. Please check the relationship between Dr Reddys Revenue Per Share and its Ebit Per Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Revenue Per Share vs Ebit Per Revenue

Revenue Per Share vs Ebit Per Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dr Reddys Laboratories Revenue Per Share account and Ebit Per Revenue. At this time, the significance of the direction appears to have very week relationship.

The correlation between Dr Reddys' Revenue Per Share and Ebit Per Revenue is 0.24. Overlapping area represents the amount of variation of Revenue Per Share that can explain the historical movement of Ebit Per Revenue in the same time period over historical financial statements of Dr Reddys Laboratories, assuming nothing else is changed. The correlation between historical values of Dr Reddys' Revenue Per Share and Ebit Per Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Revenue Per Share of Dr Reddys Laboratories are associated (or correlated) with its Ebit Per Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit Per Revenue has no effect on the direction of Revenue Per Share i.e., Dr Reddys' Revenue Per Share and Ebit Per Revenue go up and down completely randomly.

Correlation Coefficient

0.24

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Revenue Per Share

The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.

Ebit Per Revenue

Most indicators from Dr Reddys' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dr Reddys Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

At this time, Dr Reddys' Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 20.5 B in 2025, whereas Sales General And Administrative To Revenue is likely to drop 0.15 in 2025.

	2022	2023	2024	2025 (projected)
Gross Profit	203.0B	163.6B	190.4B	199.9B
Total Revenue	245.9B	279.2B	325.5B	341.8B

Gross Profit Total Revenue

Dr Reddys fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Short Term Investments	Inventory	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding
Total Assets		0.95	0.97	0.98	0.14	0.96	0.5	0.07	-0.15	0.92	1.0	0.96	0.79	0.94	0.02	0.92	-0.16	0.97	0.03	0.92	0.99	0.9	0.95	0.28	0.98	0.33
Other Current Liab	0.95		0.99	0.89	-0.15	1.0	0.57	-0.19	-0.18	0.92	0.95	0.99	0.61	1.0	-0.24	0.98	-0.28	0.99	-0.16	0.98	0.92	0.91	0.95	-0.02	0.97	0.18
Total Current Liabilities	0.97	0.99		0.91	-0.08	0.99	0.57	-0.12	-0.16	0.93	0.97	1.0	0.65	0.98	-0.17	0.97	-0.23	1.0	-0.1	0.97	0.94	0.9	0.96	0.05	0.98	0.24
Total Stockholder Equity	0.98	0.89	0.91		0.31	0.9	0.42	0.22	-0.16	0.9	0.98	0.9	0.84	0.87	0.17	0.84	-0.08	0.91	0.17	0.85	0.98	0.88	0.93	0.43	0.94	0.37
Retained Earnings	0.14	-0.15	-0.08	0.31		-0.12	-0.31	0.89	0.04	0.04	0.14	-0.12	0.54	-0.2	0.91	-0.24	0.46	-0.08	0.76	-0.21	0.2	0.01	0.03	0.97	0.01	0.41
Accounts Payable	0.96	1.0	0.99	0.9	-0.12		0.58	-0.17	-0.19	0.94	0.96	0.99	0.61	0.99	-0.22	0.98	-0.28	0.99	-0.15	0.97	0.92	0.92	0.97	0.02	0.97	0.21
Cash	0.5	0.57	0.57	0.42	-0.31	0.58		-0.38	-0.31	0.53	0.48	0.58	0.18	0.6	-0.45	0.63	-0.39	0.57	-0.37	0.49	0.46	0.39	0.56	-0.14	0.55	0.41
Other Assets	0.07	-0.19	-0.12	0.22	0.89	-0.17	-0.38		0.03	-0.11	0.08	-0.16	0.48	-0.24	0.9	-0.27	0.55	-0.13	0.81	-0.23	0.14	-0.13	-0.1	0.85	-0.04	0.29
Long Term Debt	-0.15	-0.18	-0.16	-0.16	0.04	-0.19	-0.31	0.03		-0.22	-0.17	-0.13	0.08	-0.16	0.32	-0.11	0.59	-0.13	0.05	-0.06	-0.1	-0.25	-0.23	-0.05	-0.16	0.09
Short Term Investments	0.92	0.92	0.93	0.9	0.04	0.94	0.53	-0.11	-0.22		0.93	0.92	0.56	0.9	-0.11	0.86	-0.25	0.93	-0.04	0.86	0.87	0.97	0.99	0.16	0.91	0.26
Inventory	1.0	0.95	0.97	0.98	0.14	0.96	0.48	0.08	-0.17	0.93		0.96	0.77	0.94	0.01	0.91	-0.18	0.97	0.06	0.92	0.98	0.91	0.96	0.27	0.97	0.31
Total Liab	0.96	0.99	1.0	0.9	-0.12	0.99	0.58	-0.16	-0.13	0.92	0.96		0.64	0.99	-0.21	0.99	-0.25	1.0	-0.14	0.98	0.93	0.89	0.95	0.02	0.98	0.23
Intangible Assets	0.79	0.61	0.65	0.84	0.54	0.61	0.18	0.48	0.08	0.56	0.77	0.64		0.59	0.48	0.59	0.22	0.66	0.27	0.62	0.87	0.54	0.6	0.64	0.74	0.41
Common Stock	0.94	1.0	0.98	0.87	-0.2	0.99	0.6	-0.24	-0.16	0.9	0.94	0.99	0.59		-0.29	0.99	-0.3	0.99	-0.22	0.98	0.91	0.89	0.93	-0.06	0.96	0.22
Property Plant Equipment	0.02	-0.24	-0.17	0.17	0.91	-0.22	-0.45	0.9	0.32	-0.11	0.01	-0.21	0.48	-0.29		-0.32	0.77	-0.17	0.72	-0.26	0.09	-0.12	-0.12	0.83	-0.09	0.32
Short Long Term Debt Total	0.92	0.98	0.97	0.84	-0.24	0.98	0.63	-0.27	-0.11	0.86	0.91	0.99	0.59	0.99	-0.32		-0.29	0.98	-0.26	0.99	0.9	0.84	0.9	-0.1	0.95	0.2
Other Liab	-0.16	-0.28	-0.23	-0.08	0.46	-0.28	-0.39	0.55	0.59	-0.25	-0.18	-0.25	0.22	-0.3	0.77	-0.29		-0.22	0.4	-0.25	-0.08	-0.26	-0.28	0.34	-0.22	0.25
Property Plant And Equipment Net	0.97	0.99	1.0	0.91	-0.08	0.99	0.57	-0.13	-0.13	0.93	0.97	1.0	0.66	0.99	-0.17	0.98	-0.22		-0.12	0.97	0.94	0.9	0.96	0.05	0.98	0.24
Current Deferred Revenue	0.03	-0.16	-0.1	0.17	0.76	-0.15	-0.37	0.81	0.05	-0.04	0.06	-0.14	0.27	-0.22	0.72	-0.26	0.4	-0.12		-0.22	0.06	-0.09	-0.04	0.7	-0.05	0.24
Net Debt	0.92	0.98	0.97	0.85	-0.21	0.97	0.49	-0.23	-0.06	0.86	0.92	0.98	0.62	0.98	-0.26	0.99	-0.25	0.97	-0.22		0.9	0.86	0.89	-0.08	0.95	0.14
Non Current Assets Total	0.99	0.92	0.94	0.98	0.2	0.92	0.46	0.14	-0.1	0.87	0.98	0.93	0.87	0.91	0.09	0.9	-0.08	0.94	0.06	0.9		0.84	0.9	0.33	0.97	0.35
Non Currrent Assets Other	0.9	0.91	0.9	0.88	0.01	0.92	0.39	-0.13	-0.25	0.97	0.91	0.89	0.54	0.89	-0.12	0.84	-0.26	0.9	-0.09	0.86	0.84		0.96	0.1	0.87	0.14
Cash And Short Term Investments	0.95	0.95	0.96	0.93	0.03	0.97	0.56	-0.1	-0.23	0.99	0.96	0.95	0.6	0.93	-0.12	0.9	-0.28	0.96	-0.04	0.89	0.9	0.96		0.15	0.94	0.26
Net Receivables	0.28	-0.02	0.05	0.43	0.97	0.02	-0.14	0.85	-0.05	0.16	0.27	0.02	0.64	-0.06	0.83	-0.1	0.34	0.05	0.7	-0.08	0.33	0.1	0.15		0.16	0.51
Good Will	0.98	0.97	0.98	0.94	0.01	0.97	0.55	-0.04	-0.16	0.91	0.97	0.98	0.74	0.96	-0.09	0.95	-0.22	0.98	-0.05	0.95	0.97	0.87	0.94	0.16		0.25
Common Stock Shares Outstanding	0.33	0.18	0.24	0.37	0.41	0.21	0.41	0.29	0.09	0.26	0.31	0.23	0.41	0.22	0.32	0.2	0.25	0.24	0.24	0.14	0.35	0.14	0.26	0.51	0.25

Click cells to compare fundamentals

Dr Reddys Account Relationship Matchups

Dr Reddys fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	265.5B	296.7B	322.9B	387.5B	493.0B	517.6B
Other Current Liab	45.3B	48.3B	53.5B	58.1B	66.4B	46.7B
Total Current Liabilities	81.5B	97.8B	85.7B	96.0B	130.4B	72.6B
Total Stockholder Equity	175.0B	190.5B	232.9B	280.6B	333.4B	350.1B
Retained Earnings	157.9B	175.7B	215.6B	265.3B	315.8B	331.6B
Accounts Payable	12.7B	16.0B	17.9B	21.5B	20.1B	14.2B
Cash	14.8B	14.9B	5.8B	7.1B	14.7B	14.3B
Other Assets	11.6B	13.7B	7.1B	11.7B	19.2B	20.1B
Long Term Debt	0.0	6.3B	5.7B	3.8B	4.4B	3.5B
Short Term Investments	19.7B	29.5B	61.0B	74.4B	43.3B	25.5B
Inventory	45.4B	50.9B	48.7B	63.6B	71.1B	74.6B
Total Liab	90.5B	106.1B	90.0B	107.0B	155.8B	92.6B
Intangible Assets	35.6B	27.2B	30.7B	37.0B	96.8B	101.6B
Property Plant Equipment	57.1B	62.2B	66.3B	76.0B	97.0B	101.8B
Short Long Term Debt Total	30.3B	33.8B	13.5B	20.0B	46.8B	41.7B
Other Liab	3.5B	3.1B	2.7B	2.5B	2.9B	3.1B
Property Plant And Equipment Net	57.1B	62.2B	56.5B	76.9B	97.8B	57.6B
Current Deferred Revenue	2.0B	2.6B	2.0B	1.4B	2.0B	1.9B
Net Debt	15.5B	19.0B	7.7B	12.9B	32.1B	26.8B
Non Current Assets Total	117.2B	115.5B	118.6B	139.5B	242.9B	255.0B
Non Currrent Assets Other	952M	948M	12.7B	16.1B	2.8B	4.0B
Cash And Short Term Investments	34.6B	44.4B	66.7B	81.5B	57.9B	37.1B
Net Receivables	49.6B	66.8B	72.5B	80.3B	109.8B	115.3B
Good Will	4.6B	4.4B	5.5B	4.3B	11.8B	6.7B
Common Stock Shares Outstanding	831.6M	831.7M	831.9M	833.5M	834.3M	897.3M
Liabilities And Stockholders Equity	265.5B	296.7B	322.9B	387.5B	493.0B	517.6B
Non Current Liabilities Total	9.0B	8.3B	4.3B	10.9B	25.4B	20.4B
Other Current Assets	18.6B	19.8B	21.3B	22.7B	11.3B	10.2B
Other Stockholder Equity	8.2B	8.4B	10.3B	10.4B	12.8B	12.1B
Total Current Assets	148.2B	181.1B	204.3B	248.0B	250.1B	133.7B
Accumulated Other Comprehensive Income	1.3B	1.1B	1.3B	4.0B	4.0B	3.8B
Short Term Debt	24.0B	28.1B	12.2B	14.0B	38.9B	40.8B
Property Plant And Equipment Gross	57.1B	142.0B	152.3B	170.1B	190.4B	180.9B
Net Tangible Assets	91.9B	123.3B	134.8B	158.9B	182.7B	102.9B
Long Term Investments	8.3B	8.0B	6.1B	5.3B	15.2B	16.0B
Short Long Term Debt	24.0B	28.1B	12.2B	12.7B	38.0B	24.4B
Long Term Debt Total	6.3B	5.7B	1.3B	6.0B	7.9B	6.7B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

USOI	Credit Suisse X Links
ULTY	Tidal Trust II
CONY	YieldMax N Option

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

RDY Revenue Per Share vs Ebit Per Revenue Analysis

Revenue Per Share vs Ebit Per Revenue

Revenue Per Share vs Ebit Per Revenue Correlation Analysis

Correlation Coefficient

Revenue Per Share

Ebit Per Revenue

Dr Reddys fundamental ratios Correlations

Dr Reddys Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Dr Reddys fundamental ratios Accounts

Also Currently Popular

Additional Tools for RDY Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Inventory	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Other Current Liab
Common Stock	+ 1.0	Other Current Liab
Total Liab	+ 1.0	Total Current Liabilities
Property Plant And Equipment Net	+ 1.0	Total Current Liabilities
Property Plant And Equipment Net	+ 1.0	Total Liab

Property Plant Equipment	- 0.45	Cash
Other Liab	- 0.39	Cash
Other Assets	- 0.38	Cash
Current Deferred Revenue	- 0.37	Cash
Short Long Term Debt Total	- 0.32	Property Plant Equipment
Long Term Debt	- 0.31	Cash